Preparation for radioiodine therapy in patients with differentiated thyroid cancer, modern perspective. Review of the literature.

Maria V. Ryzhenko, Konstantin Y. Slashchuk, Alexey A. Trukhin, Karina I. Avramova, Marina S. Sheremeta
{"title":"Preparation for radioiodine therapy in patients with differentiated thyroid cancer, modern perspective. Review of the literature.","authors":"Maria V. Ryzhenko, Konstantin Y. Slashchuk, Alexey A. Trukhin, Karina I. Avramova, Marina S. Sheremeta","doi":"10.17816/dd532728","DOIUrl":null,"url":null,"abstract":"Thyroid cancer is the most common tumor of the endocrine system, 1-3% of all malignant neoplasms as of 2021. Differentiated forms, papillary and follicular, with a relatively favorable prognosis, are detected in 90% of cases. In recent years, therapy for well-differentiated thyroid cancer (WDTC) has not significantly changed and includes surgical treatment, hormone therapy, radioiodine therapy when indicated, and dynamic monitoring with possible expansion to advanced therapeutic options in cases of disease recurrence. However, there are a range of unresolved issues that are continuing to be actively investigated by new laboratory and instrumental methods. Particularly, one of these issues is the preparation in patients with differentiated thyroid cancer for radioiodine therapy.
 Radioiodine therapy (RIT) is considered as one of the first targeted therapies for thyroid cancer with a history of over 80 years of use, the main purpose of which is ablation of residual thyroid tissue as well as therapy of distant and/or regional metastases of thyroid cancer. The combination of surgical treatment and subsequent radioiodine therapy provides a favorable prognosis in patients with WDTC, but there is a remaining possibility of insufficient response to radioiodine therapy, which may be associated with multiple factors, including the phase of preparation for RIT.
 The publication provides a review of the scientific literature on the aspects of preparation of patients with WDTC for radioiodine therapy. The principles of preparation are based on the recommendations of the leading expert societies and studies published in the world practice, as well as known side effects during preparation for radioiodine therapy and thereafter, their impact on patients' quality of life, effectiveness and long-term results of treatment.
 Materials and Methods
 Scientific articles and reviews from Medline, Cochrane, and Google Scholar databases were searched by keywords, and recommendations regarding WDTC of the scientific societies were used. Articles in Russian and English with full-text availability were selected; those published after January 2023 were excluded. A systematic evaluation of 130 sources was performed, general trends in the modern approach to patient preparation for radioiodine therapy and current problems were highlighted, and results and conclusions were formulated","PeriodicalId":34831,"journal":{"name":"Digital Diagnostics","volume":"28 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Digital Diagnostics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17816/dd532728","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Thyroid cancer is the most common tumor of the endocrine system, 1-3% of all malignant neoplasms as of 2021. Differentiated forms, papillary and follicular, with a relatively favorable prognosis, are detected in 90% of cases. In recent years, therapy for well-differentiated thyroid cancer (WDTC) has not significantly changed and includes surgical treatment, hormone therapy, radioiodine therapy when indicated, and dynamic monitoring with possible expansion to advanced therapeutic options in cases of disease recurrence. However, there are a range of unresolved issues that are continuing to be actively investigated by new laboratory and instrumental methods. Particularly, one of these issues is the preparation in patients with differentiated thyroid cancer for radioiodine therapy. Radioiodine therapy (RIT) is considered as one of the first targeted therapies for thyroid cancer with a history of over 80 years of use, the main purpose of which is ablation of residual thyroid tissue as well as therapy of distant and/or regional metastases of thyroid cancer. The combination of surgical treatment and subsequent radioiodine therapy provides a favorable prognosis in patients with WDTC, but there is a remaining possibility of insufficient response to radioiodine therapy, which may be associated with multiple factors, including the phase of preparation for RIT. The publication provides a review of the scientific literature on the aspects of preparation of patients with WDTC for radioiodine therapy. The principles of preparation are based on the recommendations of the leading expert societies and studies published in the world practice, as well as known side effects during preparation for radioiodine therapy and thereafter, their impact on patients' quality of life, effectiveness and long-term results of treatment. Materials and Methods Scientific articles and reviews from Medline, Cochrane, and Google Scholar databases were searched by keywords, and recommendations regarding WDTC of the scientific societies were used. Articles in Russian and English with full-text availability were selected; those published after January 2023 were excluded. A systematic evaluation of 130 sources was performed, general trends in the modern approach to patient preparation for radioiodine therapy and current problems were highlighted, and results and conclusions were formulated
分化型甲状腺癌放射碘治疗的准备,现代观点。文献回顾。
甲状腺癌是内分泌系统最常见的肿瘤,截至2021年占所有恶性肿瘤的1-3%。分化形式,乳头状和滤泡状,预后相对较好,在90%的病例中检测到。近年来,高分化甲状腺癌(WDTC)的治疗方法没有明显变化,包括手术治疗、激素治疗、有指证时的放射性碘治疗,以及动态监测,并可能在疾病复发时扩展到先进的治疗选择。然而,仍有一系列未解决的问题,正在继续通过新的实验室和仪器方法积极研究。特别是,其中一个问题是分化型甲状腺癌患者放射碘治疗的准备。 放射性碘疗法(RIT)被认为是甲状腺癌最早的靶向治疗方法之一,已有80多年的使用历史,其主要目的是消融甲状腺残留组织以及治疗甲状腺癌的远处和/或局部转移。手术联合放射碘治疗可为WDTC患者提供良好的预后,但仍有可能对放射碘治疗反应不足,这可能与多种因素有关,包括RIT的准备阶段。 该出版物对放射性碘治疗WDTC患者的制备方面的科学文献进行了综述。准备原则是根据主要专家协会的建议和在世界实践中发表的研究报告,以及放射性碘治疗准备期间及其之后的已知副作用,对患者生活质量的影响,治疗的有效性和长期结果。材料与方法 通过关键词检索Medline、Cochrane和Google Scholar数据库中的科学文章和综述,并使用有关科学学会WDTC的推荐。选择有全文的俄文和英文文章;2023年1月以后发表的论文被排除在外。对130个来源进行了系统评价,强调了现代病人准备放射性碘治疗方法的一般趋势和目前存在的问题,并制定了结果和结论
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.30
自引率
0.00%
发文量
44
审稿时长
5 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信